Metabolism Disorder TRIZ Cases

PLGA microspheres release exenatide to protect encapsulated islets from hypoxia and oxidative stress during transplantation.

Specific geometric parameters including height-to-width ratios and controlled cup depths prevent surface cracking during manufacturing.

Copper or zinc salts complex with peptide drugs to inhibit gastrointestinal proteases and enhance oral bioavailability.

Triphosphate reduces Tmax by 50% to resolve slow onset and postprandial hyperglycemia.

Chitin-glucan copolymers from Aspergillus niger reduce triglycerides and LDL cholesterol while increasing HDL levels.

A solid food composition reduces blood glucose levels through beta-glucan and incretin activation.

MC4R agonists lower plasma leptin and reduce renal IL-23 expression to improve renal dysfunction in chronic kidney disease patients.

Titration schedules minimize adverse side effects while maintaining treatment efficacy for obesity medications.

Targeting HDAC11 expression promotes brown adipose tissue activity while preventing white adipose tissue production to treat metabolic syndrome.

Truncated ATP7B genes in AAV vectors overcome packaging limits, restoring liver function.

Cooked millet prolamin peptides inhibit alpha-amylase and alpha-glucosidase, offering a safe alternative to synthetic drugs that cause flatulence and diarrhea.

PEG-Exenatide conjugates extend half-life to 80 hours, reducing injection frequency from twice daily to weekly.

Functionalized redox-reactive nanostructures enable multiplex sensing of cellular metabolic activity in physiological solutions.

Optimized SIRS polypeptide variants delay disease onset and decrease relapse frequency by increasing immunosuppressive cytokines.

A CXCL12 polypeptide eluting matrix repels effector T-cells and recruits regulatory T-cells to protect transplanted cells.

Fully human monoclonal antibodies bind insulin-like growth factor II with cross-reactivity to IGF-I, blocking receptor signaling to inhibit tumor growth.

A synergistic composition combining red yeast rice extract, omega-3 fatty acids, and policosanol to lower cholesterol.

Bioprinted multilayer vascular tubes eliminate pre-formed scaffolds to resolve compliance and thrombosis trade-offs in small-diameter grafts.

Direct somatic cell reprogramming into brown adipocytes using specific gene combinations to generate high UCP1 expression levels.

An anti-ITGA11 antibody induces cytotoxicity to remove senescent cells.

A resveratrol-loaded micellar composition reduces localized fat through subcutaneous adipocyte apoptosis.

Derivatizing succinylacetone with hydrazine and monoalcohol enables extraction without altering other metabolites, preserving metabolic profile accuracy.

Sublingual insulin-related peptide formulations attenuate antigenic responses, delaying pancreatic beta cell loss and preserving serum C-peptide levels.

Endothelin-A antagonists block receptor activation to prevent insulin-induced hypertension and cerebral edema while maintaining standard treatment efficacy.

Ripening-impaired mutant tomatoes inhibit pre-adipocyte differentiation, addressing ineffective long-term weight management from current diets and drugs.

Antibodies targeting TMEM219 prevent IGFBP3 binding, preserving beta cells and controlling blood glucose levels in diabetic enteropathy.

Dissolving apoaequorin tablets restore calcium balance while eliminating pill-swallowing barriers and side effects.

An ANGPTL3 inhibitor antibody lowers serum cholesterol and triglycerides to reduce atherosclerotic plaque formation.

AhR agonist-producing probiotics correct impaired gut receptor function to treat metabolic syndrome without pharmacological side effects.

Microbial hydrolysis of soy glycinin yields peptides that inhibit lipases while protecting against oxidative stress.

Fatty acid modification of IL-22 avoids immunogenicity from Fc fusion and activity loss from PEGylation, delivering prolonged therapeutic effects.

Specific Lactobacillus and Bifidobacterium strains inhibit fatty acid uptake to treat obesity without the side effects of conventional medications.

A postbiotic composition comprising lysates from Bacillus, Bifidobacterium, and other genera treats dyslipidemia by modulating host microbiota.

Specific halogen and deuterium substitutions on phenyl ether structures improve THR-beta selectivity while resolving unpredictable pharmacokinetic changes.

Magnesium maltol complexes resolve low solubility and high cost barriers in oral supplementation by forming stable chelates via maltol coordination.

Alkalinizers maintain microenvironmental pH above 7 to stabilize hypolipidemic compounds against oxidation and hydrolysis.

Replacing phenylalanine with tryptophan in recombinant proteins manages blood levels while preserving nutritional value.

Saskatoon berry extract chelates iron with organic acids to prevent oxidation in the digestive tract, enhancing absorption while reducing skin spots.

A 5HT3R antagonist reduces aortic diameter and aneurysm incidence through serotonin receptor blockade.

A synergistic combination of cinnamon and Radix Astragali water extracts overcomes the complexity and safety trade-offs of traditional weight reduction methods.

An MKRN1 inhibitor suppresses the E3 ligase to restore AMPK protein levels and improve metabolic health.

Isolating brown adipose tissue stem cells using specific surface markers for therapeutic applications.

HBV-derived polypeptide regulates NTCP-mediated bile acid transport bidirectionally, reducing metabolic disease treatment complexity.

Oral amino acid secretagogue composition stimulates pituitary gland release of human growth hormone through synergistic blend.